Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: J Am Pharm Assoc (2003). 2022 Apr 12:S1544-3191(22)00123-6. doi: 10.1016/j.japh.2022.04.005

Table 3.

Identified medication-related concerns and interventions by type

Patients, n (%)
(N = 100)
Identified medication-related concem(s)*
 Inappropriate or unnecessary therapy 41 (41)
 Suboptimal therapy 40 (40)
 Undertreated symptoms 34 (34)
 Adverse drug event 33 (33)
 Drug-drug interaction 32 (32)
 Duplication of therapy 29 (29)
 Unclear prescription instructions 11 (11)
 None 9 (9)
Identified intervention(s)*
 Drug discontinuation 69 (69)
 Patient/caregiver education 55 (55)
 Dosage form modification 51 (51)
 Dose modification 49 (49)
 Dosing frequency modification 46 (46)
 Initiation of drug therapy 23 (23)
 Change to alternative medication 21 (21)
 Laboratory monitoring for safety/efficacy 4 (4)
 None 3 (3)
*

Neither concern nor intervention subcategories were mutually exclusive.

Education interventions referred to those intended to prevent administration errors on a recurring basis (e.g., compounded liquid medication volume/concentration, appropriate injection technique for parenteral medications).